08Jan/13

IncellDx Presents First Study Using Their Novel OncoBreast 3Dx‚Ñ¢ Breast … – PharmiWeb.com (press release)

IncellDx Presents First Study Using Their Novel OncoBreast 3Dx‚Ñ¢ Breast
PharmiWeb.com (press release)
About IncellDx, Inc. IncellDx, Inc. is a molecular diagnostics company dedicated to the detection and monitoring of life threatening diseases such as cervical cancer, breast cancer, HIV/AIDs, hepatitis, and organ transplant rejection. For more

and more »

08Jan/13

IncellDx Presents First Study Using Their Novel OncoBreast 3Dx™ Breast … – The Herald | HeraldOnline.com

IncellDx Presents First Study Using Their Novel OncoBreast 3Dx™ Breast
The Herald | HeraldOnline.com
3Dx platform,” he added. About IncellDx, Inc. IncellDx, Inc. is a molecular diagnostics company dedicated to the detection and monitoring of life threatening diseases such as cervical cancer, breast cancer, HIV/AIDs, hepatitis, and organ transplant

and more »

08Jan/13

CardioKinetix Initiates Landmark Study of First-of-Its-Kind Treatment for … – PharmiWeb.com (press release)

CardioKinetix Initiates Landmark Study of First-of-Its-Kind Treatment for
PharmiWeb.com (press release)
CardioKinetix Inc., a medical device company pioneering a catheter-based treatment for heart failure, announced the enrollment of the first patients in PARACHUTE IV, the randomized pivotal U.S. trial of the minimally invasive Parachute‚Ñ¢ Ventricular

and more »